Evidence map›Paper›PMID 23064115›Full record

ArticleRNA biology2012

Emerging views about the molecular structure of the spliceosomal catalytic center.

Jana Schmitzová, Vladimir Pena

Open access · hybridAbstract read
In one paragraph

Article in RNA biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jana SchmitzováDepartment of Cellular Biochemistry, Max Planck Institute for Biophysical, Macromolecular Crystallography Group, Göttingen, Germany.
Vladimir Pena
Max Planck Institute for Biophysical Chemistry · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pre-mRNA splicing occurs in two chemical steps that are catalyzed by a large, dynamic RNA-protein complex called the spliceosome. Initially assembled in a catalytically inactive form, the spliceosome undergoes massive compositional and conformational remodeling, through which disparate RNA elements are re-configured and juxtaposed into a functional catalytic center. The intricate construction of the catalytic center requires the assistance of spliceosomal proteins. Recent structure-function analyses have demonstrated that the yeast-splicing factor Cwc2 is a main player that contacts and shapes the catalytic center of the spliceosome into a functional conformation. With this advance, corroborated by the atomic structure of the evolutionarily related group IIC introns, our understanding of the organization and formation of the spliceosomal catalytic center has progressed to a new level.

Indexed as

RNA Splice SitesCarrier ProteinsCatalysisCatalytic DomainHumansIntronsNucleic Acid ConformationRNA-Binding ProteinsRNA, MessengerRNA PrecursorsRNA, Small NuclearRNA SplicingSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSpliceosomesCarrier ProteinsCwc2 protein, S cerevisiaePRPF8 protein, humanRNA-Binding ProteinsRNA, MessengerRNA PrecursorsRNA, Small NuclearRNA Splice SitesSaccharomyces cerevisiae ProteinsCwc2Domain Vgroup II intronsPrp8RNA-protein interactionRNA splicingRNA tertiary interactionsspliceosomesplicing catalysisU6-ISL

Identifiers

PMID23064115
PMCPMC3597571
OpenAlexW2029811282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.